Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


3-day Agilent H4063A Mass Spectral Interpretation course

13 May 2013 - 15 May 2013 - Milton Keynes, UK



Bookmark and Share


What will I learn on this course?

This three-day course is designed to present the fundamental concepts necessary to obtain high-quality data in SCAN mode from a GC-MS System for spectral interpretation purposes. The most commonly employed tools used in identifying compounds based on their mass spectra are introduced, the physical reasons for their efficiency explained, and their use reinforced through problem solving. The most common decomposition mechanisms responsible for fragment ions will also be introduced. This course is classroom based and combines a mixture of presentations to introduce the concepts with a high proportion of lab exercises to reinforce the knowledge.

If you wish to delve further into mass spectrometry in order to identify unknown spectra and evaluate MS library database search results using a modern mass spectrometer and data system, then this course for you. This provides only an introduction to mass spectral interpretation. 

Is this course for me?

This course is recommended for those who have a good background in organic chemistry and at least six months experience as a GC-MS operator 

Course Venue

Agilent Centre of Excellence, The Open University, Milton Keynes, UK

More Information

For more information or a course outline, please email courses@anthias.co.uk



Further information
Scientific News
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
A Metabolic Twist that Drives Cancer Survival
A novel metabolic pathway that helps cancer cells thrive in conditions that are lethal to normal cells has been identified.
Liver-On-Chip Tracks Dynamics of Cellular Function
Hebrew University’s liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe.
Living Off the Fat of the Land
Do cancer cells synthesize the parts for new cells or scavenge them from the environment?
Liver Disease, Obesity Linked
Kanazawa University researchers find similarities in the impeded signalling between central insulin activity and glucose production in the liver for both obese mice and mice that have had the vagus nerve removed.
Decoding Ties Between Vascular Disease, Alzheimer’s
NIH consortium uses big data, team science to uncover complex interplay of factors.
Gene Identified that May Worsen Cancer Outcome
Some patients with breast cancer, lung cancer and leukaemia seem to fare poorly after treatment because of the effects of a particular gene, a new study finds.
‘Big Data’ Drills Down Into Metabolic Details
Rice University bioengineers introduce efficient way to analyze, compare tissue-specific pathways.
New Approach to Curbing Cancer Cell Growth
Using a new approach, scientists at The Scripps Research Institute (TSRI) and collaborating institutions have discovered a novel drug candidate that could be used to treat certain types of breast cancer, lung cancer and melanoma.
New Drug Delivery Method for Pancreatic Cancer
UCLA researchers use nanoparticles to send chemotherapy drug directly to the tumor site, reducing damage to healthy tissues.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!